SAMDaily.us | SNOTE | B | SINGLE-DOMAIN ANTIBODY GENERATION SERVICES

SAMDAILY.US - ISSUE OF AUGUST 10, 2023 SAM #7926
SPECIAL NOTICE

B -- SINGLE-DOMAIN ANTIBODY GENERATION SERVICES

Notice Date: 8/8/2023 1:14:32 PM
Notice Type: Special Notice
Contracting Office: NATIONAL INSTITUTES OF HEALTH OLAO BETHESDA MD 20892 USA
ZIP Code: 20892
Solicitation Number: NIHNEI080823
Response Due: 8/10/2023 5:00:00 AM
Archive Date: 08/25/2023
Point of Contact: Sharmaine Fagan, Phone: 3015943744
E-Mail Address: sharmaine.fagan@nih.gov
(sharmaine.fagan@nih.gov)
Description: The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price purchase order to ProSci, Llc. for�custom services order� to develop recombinant single-domain antibodies (sdAbs) by llama immunization. In accordance with FAR Part 6.302-1, the Contractor is the only known responsible source who can provide the specific continued single-domain antibody generation services per SOW below.�This notice is not a request for competitive quotes. However, any party that believes it can provide the services as�stated herein may submit a written capability statement that clearly supports and demonstrates their ability to satisfy the requirement. A determination by the Government to compete this proposed award based upon responses to this notice is solely within the discretion of the Government. It is anticipated that an award will be issued approximately five (5) days after the date of this notice unless the Government determines that another organization has the capability to meet this requirement. Please email responses to Sharmaine.fagan@nih.gov no later than 08:00 a.m. EST on Thursday, August 10, 2023. SCOPE: The primary objective of this custom services order through ProSci, Llc., is to develop recombinant single-domain antibodies (sdAbs) by llama immunization. sdAbs are very compact antibodies that are used for a variety of basic research and translational procedures. sdAbs are isolated from camelid (such as llama) heavy-chain-only antibodies and are comprised of only the variable domain. As such, they lack light chains, are smaller and more stable compared to conventional antibodies, yet possess fully functional antigen-binding capability. Due to their size (approximately 15 kDa, one-tenth the size of conventional antibodies) and their longer CDR3 region, a single domain antibody can reach otherwise inaccessible epitopes. Phage display technology is used to develop functional single domain antibodies. We wish to develop sdAbs against retinal pigment epithelium proteins including RPE65 for use in biochemical and structural biology downstream experiments. This contract is construed to provide a sdAb library such that appropriate sdAb clones can later be identified and produced for downstream use. TASKS/SERVICES:� The contractor shall perform the following tasks and procedures: Phase� �� Weeks �� Procedure�� Detailed Procedure I�� 12 weeks�� Immunization�� 1) Immunization of 1 llama on standard �� 12-week protocol �� 2) ELISA testing of serum II�� 1 week�� PBMC isolation�� PBMCs isolated and preserved from �� blood collected at weeks 8 and 12 III�� 2-3 weeks�� Library Construction� �� sdAb library construction from Phase II �� PBMCs (either bleed 2 or 3) Following development of the library, the Government may submit an additional contract to the contractor for sdAb clone selection and sequencing and/or small scale sdAb production. DELIVERABLES: � The primary deliverable is the sdAb library. Upon request, the contractor shall provide documentation evidence of any and/or all work products. EQUIPMENT, CERTIFICATIONS, LICENSE, PHYSICAL REQUIREMENTS OR OTHER EXPERTISE REQUIRED: The contractor must have state of the art skills in antibody generation and production, analytical workflows, data analysis and interpretation capabilities. Be up-to-date in antibody phage display library construction, panning, and screening methods. PLACE OF PERFORMANCE: The place of performance is the contract company labs and facilities. �� OPERATIONAL HOURS: Procedures and analyses will be performed at times/days at the operational discretion of staff of the ProSci, LLC. SAFETY ISSUES: Work is performed in a laboratory setting. Lab coats, safety glasses, gloves, etc. that may be required for procedures will be provided by ProSci, LLC. GOVERNMENT-FURNISHED EQUIPMENT, SUPPLIES AND/OR FACILITIES PROVIDED: Immune antigens (native RPE membranes, expressed proteins, etc.) as necessary, will be provided. OPTIONS: This agreement may be extended for an additional year, or years, contingent upon mutual agreement of the parties. PAYMENT: Payment shall be made via submission of invoices. NON-PERSONAL SERVICE STATEMENT: Contractor employees performing services under this order will be controlled, directed and supervised at all times by management personnel of the contractor.� The contractor�s management shall ensure that employees properly comply with the performance standards outlined in the Performance Evaluation Standard (PES).� Contractor employees will perform independent of and without the supervision of any Government official.� Actions of contractor employees may not be interpreted or implemented in any manner that results in any contractor employee creating or modifying Federal policy, obligating the appropriated funds of the U.S. Government, overseeing the work of Federal employees, providing direct personal services to any Federal employee or otherwise violating the prohibitions set forth in Parts 7.5 and 37.1 of the Federal Acquisition Regulation (FAR).� The Government will perform the inspection and acceptance of the completed work.
Web Link: SAM.gov Permalink
(https://sam.gov/opp/089d5a3e87564151ae875cb47ecbb36e/view)
Place of Performance: Address: Rockville, MD 20852, USA; Zip Code: 20852; Country: USA
Record: SN06780525-F 20230810/230808230055 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |

Loren Data's SAM Daily™

B -- SINGLE-DOMAIN ANTIBODY GENERATION SERVICES